Showing results (471-480 of 586) with videos related to
Sort By:
Pageof 59
Artificial Cells, Nanomedicine, and Biotechnology|May 2, 2023
The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysisKi-Kwang Oh, Haripriya Gupta, Raja Ganesan, et al.Cancers|March 13, 2024
Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir TherapyHyung Joon Yim, Seong Hee Kang, Young Kul Jung, et al.Gut and Liver|April 7, 2026
Liver Failure versus Organ Failure in Acute-on-Chronic Liver Failure: Sequence and ConsequenceYoung Chang, Jae Young Jang, Soung Won Jeong, et al.Journal of Clinical Medicine|October 19, 2019
The Impact of Previous Acute Decompensation on the Long-Term Prognosis of Alcoholic Hepatitis in Cirrhotic PatientsEileen L Yoon, Tae Yeob Kim, Do Seon Song, et al.Journal of Microbiology (Seoul, Korea)|March 5, 2025
Synbiotic combination of fructooligosaccharides and probiotics ameliorates the metabolic dysfunction-associated steatotic liver diseaseSang Yoon Lee, Su-Been Lee, Goo-Hyun Kwon, et al.Plos One|July 31, 2018
Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter studyBaek Gyu Jun, Young Don Kim, Sang Gyune Kim, et al.International Journal of Molecular Sciences|August 26, 2022
The Link between Gut Microbiota and Hepatic EncephalopathySung-Min Won, Ki Kwang Oh, Haripriya Gupta, et al.Hepatology International|July 24, 2015
The virological response in Koreans infected with HCV genotype 1 did not differ between groups treated with a full dose or reduced dose (≥80 % full dose) of peginterferon alfa-2a: a prospective randomized multicenter trialJung Hyun Kwon, Si Hyun Bae, Youn Jae Lee, et al.Artificial Cells, Nanomedicine, and Biotechnology|April 30, 2024
A consortium of Hordeum vulgare and gut microbiota against non-alcoholic fatty liver disease via data-driven analysisSu-Been Lee, Haripriya Gupta, Byeong-Hyun Min, et al.Biomedicines|March 25, 2022
Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic RoleHaripriya Gupta, Byeong-Hyun Min, Raja Ganesan, et al.Pageof 59